Correspondence

Ivermectin for COVID-19: Promising but not yet conclusive
Abstract
Ivermectin has been proposed as a potential definitive and prophylactic treatment for COVID-19. Ivermectin is an anthelmintic drug that is usually indicated for filarial and resistant scabies infections, but has been shown to have antiviral activity and anti-inflammatory activity in vitro. Ivermectin has the potential to
be a promising directed therapy in the drug armamentarium against
COVID-19, as it has been shown to have in vitro activity against
SARS-CoV-2.
Authors' affiliations
R van Rensburg, Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
E H Decloedt, Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
H Reuter, Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
A Parker, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
N Schrueder, Division of General Internal Medicine, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa
S Lahri, Emergency physician, Khayelitsha Hospital; and Division of Emergency Medicine, Department of Family Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
Full Text

Cite this article
Article History
Date published: 2021-01-12
Article Views
Full text views: 2497
Comments on this article
*Read our policy for posting comments here